One of today's notable stocks on the rise is Novo Nordisk (NYSE:NVO), up 1.6% to $175.71. The S&P is currently trading 0.3% lower to 1,527 and the Dow Jones Industrial Average is trading fractionally lower to 14,034.
Novo Nordisk (NYSE:NVO) has potential upside of 7.4% based on a current price of $175.71 and analysts' consensus price target of $188.65. The stock should find initial support at its 50-day moving average (MA) of $172.21 and further support at its 200-day MA of $156.86.
Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
In the past 52 weeks, shares of Novo Nordisk have traded between a low of $129.41 and a high of $194.44 and are now at $175.71, which is 36% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.3%.